HER-2 POSITIVE ADVANCED SOLID TUMORS

Clinical trials for HER-2 POSITIVE ADVANCED SOLID TUMORS explained in plain language.

Never miss a new study

Get alerted when new HER-2 POSITIVE ADVANCED SOLID TUMORS trials appear

Sign up with your email to follow new studies for HER-2 POSITIVE ADVANCED SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First human trial launches for experimental cancer drug targeting HER2 tumors

Disease control Recruiting now

This is the first human study of an experimental drug called D3L-001 for people with advanced cancers that test positive for a protein called HER2. The main goal is to find a safe dose and check for side effects in about 128 participants. Researchers will also gather early inform…

Matched conditions: HER-2 POSITIVE ADVANCED SOLID TUMORS

Phase: PHASE1 • Sponsor: D3 Bio (Wuxi) Co., Ltd • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

HER-2 POSITIVE ADVANCED SOLID TUMORS

Get alerted when new HER-2 POSITIVE ADVANCED SOLID TUMORS trials appear

First human trial launches for experimental cancer drug targeting HER2 tumors